Evidence map›Paper›PMID 35452191›Full record

ArticleClinical and translational medicine2022

Kindlin-1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.

Paula Azorin, Florian Bonin, Zakia Tariq, Ambre Petitalot, Florence Coussy, Elisabetta Marangoni, Veronique Becette, Yves Denoux, Anne Vincent-Salomon, Christophe Le Tourneau and 6 more

Open access · goldAbstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Paula AzorinPharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.
Florian BoninPharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.
Zakia TariqPharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.
Ambre PetitalotPharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.
Florence CoussyDepartment of Medical Oncology, Institut Curie, Paris, France.
Elisabetta MarangoniTranslational Research, Institut Curie, PSL Research University, Paris, France.
Veronique BecettePathology Department, Institut Curie, Paris, France.
Yves DenouxPathology Department, Foch Hospital, Suresnes, France.
Anne Vincent-SalomonPathology Department, Institut Curie, Paris, France.
Christophe Le TourneauDepartment of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris & Saint Cloud, France.
Linda Larbi CherifDepartment of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris & Saint Cloud, France.
Jerzy KlijanienkoPathology Department, Institut Curie, Paris, France.
Maud KamalDepartment of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris & Saint Cloud, France.
Ivan BièchePharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.
Rosette LidereauPharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.
Keltouma DriouchPharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.ORCID 0000-0002-0077-4749
Institut Curie · FRUniversité Paris-Saclay · FRHôpital Foch · FRUniversité Paris Sciences et Lettres · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Membrane ProteinsNeoplasm ProteinsNeoplasmsErbB ReceptorsHumansEGFR protein, humanErbB ReceptorsFERMT1 protein, humanMembrane ProteinsNeoplasm Proteins

Identifiers

PMID35452191
PMCPMC9029018
OpenAlexW4224257366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.